Pfeffer K, Mak T W
Amgen Institute, Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Annu Rev Immunol. 1994;12:367-411. doi: 10.1146/annurev.iy.12.040194.002055.
Gene targeting by homologous recombination in pluripotent embryonic stem cells enabled the systematic creation of mouse strains with defined genetic alterations. During the past few years a rapidly growing number of gene targeted mice has provided new insights into development, selection, activation, and signaling of T and B cells, as well as into the functions of cytokines. Here we discuss the present state of targeting technology and summarize the phenotypic changes observed in gene targeted mouse strains of immunological interest. These data allow us for the first time to define genetic checkpoints in lymphocyte development that are crucial for the orderly progression of T and B cells through ontogeny and for the generation of an immune response.
通过多能胚胎干细胞中的同源重组进行基因打靶,能够系统地创建具有特定基因改变的小鼠品系。在过去几年中,基因打靶小鼠的数量迅速增加,这为T细胞和B细胞的发育、选择、激活及信号传导,以及细胞因子的功能提供了新的见解。在此,我们讨论基因打靶技术的现状,并总结在具有免疫研究价值的基因打靶小鼠品系中观察到的表型变化。这些数据首次使我们能够确定淋巴细胞发育中的基因检查点,这些检查点对于T细胞和B细胞在个体发育过程中的有序进展以及免疫反应的产生至关重要。